ANL

ADLAI NORTYE LTD

ANL·00704R109·US·ADR·Healthcare - Biotechnology-13D/G

ANL (ADLAI NORTYE LTD) is held by 12 institutional investors as of Q1 2026. Largest holders: BALYASNY ASSET MANAGEMENT L.P. ($6.1M), MILLENNIUM MANAGEMENT LLC ($4.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($3.7M). Net institutional sentiment: Bullish.

12
Holders
Avg rating(2 Elite)
$19.9M
Total Value
100% (12)
Fund Consensus
12 buying - 0 selling
ANLSmart Money Verdict
View all
Held by 12 funds
2 elite
Who's Trading
ActivistCACormorant Asset Management, LP5.2%May 15, 2026
ActivistJYJIN YIN (BVI) LIMITED2.9%May 14, 2026
InsiderLYLU YANGSell $131.8May 13, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.6.1%Feb 11, 2026
ActivistUMUnique Mark Ventures Ltd0.0%Feb 9, 2026
ActivistATANL Talent Limited7.8%Jan 16, 2026
ActivistBIBoary Investment Co. Ltd.4.8%Apr 29, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
877,846$6.1M0.0%+23.22%
38
New
681,775$4.7M0.0%+23.22%
37
New
538,461$3.7M0.0%+23.22%
37
New
209,259$1.4M0.0%+23.22%
35
Increased
122,261(+112x)$846,0460.0%+24.06%
40
New
120,156$831,4790.0%+23.22%
34
New
99,843$691,0000.0%+23.22%
34
New
66,034$456,9550.0%+23.22%
33
New
66,000$456,7200.0%+23.22%
33
New
40,310$278,9450.0%+23.22%
32
New
35,746$247,3620.0%+23.22%
32
New
11,133$77,0400.0%+23.22%
33

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used